Skip to content

Avantor AVTR Long-term debt, gross

Long-term debt, gross at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
Westlake logo
WestlakeWLK
Entegris logo
EntegrisENTG
Revvity logo
RevvityRVTY

Other financials

Income statement

See full
Revenue$1.6B0.0%
Gross profit$500.7M-6.4%
Operating income$99.5M-32.5%
Net income$43.3M-32.9%
EPS (diluted)$0.06-33.3%

Balance sheet

See full
Cash & equivalents$282.2M-11.4%
Total debt$3.8B-7.1%
Total equity$5.6B-8.4%
Total assets$11.7B-5.4%

Cash flow

See full
Operating cash flow$58.7M-46.3%
CapEx$33.5M+19.6%
Free cash flow$25.2M-69.0%

Valuation

See full
Market cap$6.54B-52.0%
Enterprise value$10.07B-40.4%
P/S-1.0×

Profitability

See full
Gross margin32.1%-1.4pp
Operating margin4%-5.2pp
Net margin-9.2%-19.9pp
FCF margin6.7%-3.3pp

Returns & leverage

See full
Return on equity-10.3%-22.8pp
Debt / equity0.7×0.0×
Current ratio1.8×+0.6×

Where this comes from

Reported directly by Avantor in its filing.

Tagged under the XBRL concept us-gaap:DebtInstrumentCarryingAmount.

The official record: Avantor’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Avantor's long-term debt, gross.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Avantor's long-term debt, gross?
Avantor (AVTR) reported long-term debt, gross of $3.84B in Q1 2026.
How has Avantor's long-term debt, gross changed year-over-year?
Avantor's long-term debt, gross decreased by 7.1% year-over-year, from $4.13B to $3.84B.
What is the long-term trend for Avantor's long-term debt, gross?
Over 5 years (2020 to 2025), Avantor's long-term debt, gross has grown at a -4.4% compound annual growth rate (CAGR), from $4.97B to $3.97B.